AVNS AVANOS MEDICAL, INC.companySEC Filings & Insider Trading Activity 2026
Latest AVANOS MEDICAL, INC. (AVNS) SEC EDGAR filings in 2026, including the most recent 10-K annual report filed on February 24, 2026, a 10-Q quarterly report filed on May 5, 2026, an 8-K current report filed on July 30, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for AVANOS MEDICAL, INC. (AVNS) (SEC CIK 1606498), with AI-powered section-by-section summaries updated daily.
Latest 2026 SEC Filing Dates
Go deeper on AVANOS MEDICAL, INC.
Ask AI about AVNS filings. Chat with the 10-K, 10-Q, and 8-K for instant answers on financials, risks, and guidance.
Track institutional money. See which funds are building or cutting AVNS positions, quarter over quarter.
Catch cross-signals. Spot when insider buying, fund accumulation, and activist stakes line up on AVNS.
Recent 8-K FilingsCurrent Reports
AI-powered analysis of AVANOS MEDICAL, INC. (AVNS) 8-K current reports disclosing material events.
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing Date | Period | Analysis | SEC |
|---|---|---|---|---|
8-K | Jul 30, 2026 | - | - | - |
8-K | Jul 22, 2026 | - | - | - |
8-K | Jul 15, 2026 | - | - | - |
8-K | Jul 2, 2026 | - | - | - |
10-Q | May 5, 2026 | Mar 31, 2026 | - | |
8-K | May 5, 2026 | - | - | - |
8-K | Apr 14, 2026 | - | - | - |
8-K | Mar 12, 2026 | - | Analysis | - |
8-K | Feb 26, 2026 | - | Analysis | - |
8-K | Feb 24, 2026 | - | Analysis | - |
10-K | Feb 24, 2026 | Dec 31, 2025 | - | |
8-K | Jan 13, 2026 | - | - | |
8-K | Dec 5, 2025 | - | - | |
10-Q | Nov 5, 2025 | Sep 30, 2025 | - | |
10-Q | Aug 5, 2025 | Jun 30, 2025 | - | |
10-Q | May 6, 2025 | Mar 31, 2025 | - | |
10-K | Feb 26, 2025 | Dec 31, 2024 | - | |
SC 13G | Nov 14, 2024 | - | - | |
10-Q | Oct 30, 2024 | Sep 30, 2024 | - | |
10-Q | Jul 31, 2024 | Jun 30, 2024 | - | |
10-Q | May 2, 2024 | Mar 31, 2024 | - | |
10-K | Feb 21, 2024 | Dec 31, 2023 | - | |
10-Q | Nov 1, 2023 | Sep 30, 2023 | - | |
10-Q | Aug 9, 2023 | Jun 30, 2023 | - | |
10-Q | May 3, 2023 | Mar 31, 2023 | - |
13F Fund Holdings: Quarterly Trend
Latest: Q1 2026Aggregate AVNS share value held by 13F filers tracked by SignalX, by quarter.
- BlackRock+92.8K (+1%)
- Goldman Sachs Group+29.5K (+7%)
- Bank of America Corp+25.8K (+30%)
- State Street Corp+17.7K (+1%)
- Northern Trust+15.9K (+3%)
- Millennium Management718.1K (-98%)
- D.E. Shaw & Co539.0K (-45%)
- Morgan Stanley266.4K (-24%)
- Dimensional Fund Advisors105.2K (-5%)
- Two Sigma Investments76.1K (-46%)
- Franklin Resources+189.0K
- Vanguard Group Inc−3.53M
- JPMorgan Chase & Co−273.7K
- Invesco Ltd−223.3K
- TOMPKINS FINANCIAL CORP−2
Source: 13F-HR filings on SEC EDGAR (aggregated from 193 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe.
Frequently Asked Questions
What are the latest AVNS SEC filings in 2026?
AVANOS MEDICAL, INC. (AVNS) has filed a 10-K annual report on February 24, 2026, a 10-Q quarterly report on May 5, 2026, an 8-K current report on July 30, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.
When did AVNS file its most recent 10-K annual report?
AVANOS MEDICAL, INC. (AVNS) filed its most recent 10-K annual report on February 24, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.
How do I view AVNS 10-Q quarterly reports?
AVANOS MEDICAL, INC. (AVNS)'s most recent 10-Q quarterly report was filed on May 5, 2026. SignalX displays every AVNS 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.
What 8-K current reports has AVNS filed recently?
AVANOS MEDICAL, INC. (AVNS)'s most recent 8-K was filed on July 30, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.
Where can I find AVNS insider trading activity (Form 4)?
SignalX aggregates every AVNS Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.
How often does AVNS file with the SEC?
AVANOS MEDICAL, INC. (AVNS) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new AVNS filing with AI-powered analysis.
What is the difference between 10-K, 10-Q, and 8-K SEC filings?
A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for AVANOS MEDICAL, INC. (AVNS).
What is AVNS's SEC CIK number?
AVANOS MEDICAL, INC. (AVNS)'s SEC CIK (Central Index Key) number is 1606498. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1606498 to look up all AVNS filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.
Stay on top of AVANOS MEDICAL, INC. SEC filings
Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 75+ filings.